overview

OxThera is a clinical stage biotechnology company based in Sweden and Florida. The company develops products, based on its cell and enzyme based proprietary technologies, for metabolic disorders based on excess oxalate from endogenous and exogenous sources.

products

Oxabact™: is an oral product consisting of lyophilized live Oxalobacter formigenes cells, which is an oxalate-degrading bacterium isolated from human gut formulated in enteric-coated capsules.

Oxazyme™: is a non-systemic orally delivered formulation consisting of recombinant oxalate degrading enzyme.